Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Amyloid 55%
3. Cognitive Dysfunction 44%
4. Atrophy 40%
5. Neuroimaging 34%
6. Brain 32%
7. Biomarkers 30%
8. White Matter 25%
9. Magnetic Resonance Imaging 24%
10. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 22%
11. Dementia 20%
12. Positron-Emission Tomography 19%
13. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 16%
14. Temporal Lobe 15%
15. Pathology 15%
16. Cognition 12%
17. Progressive Supranuclear Palsy 11%
18. Cerebrospinal Fluid 10%
19. Gray Matter 10%
20. Elderly 9%
21. Aphasia 9%
22. Hippocampus 8%
23. Frontotemporal Dementia 8%
24. Apraxias 8%
25. Primary Progressive Aphasia 8%
26. Frontotemporal Lobar Degeneration 8%
27. Memory 7%
28. Apolipoprotein E4 7%
29. Diffusion Tensor Imaging 6%
30. Disease Progression 6%
31. Clinical Trials 6%
32. Parietal Lobe 5%
33. Anisotropy 5%
34. Population 5%
35. Atherosclerosis 5%
36. Mental Status and Dementia Tests 5%
37. Amyloid Plaques 5%
38. Mutation 5%
39. Apolipoproteins E 5%